Siren »

Medline shares owned by Siren

Quarter-by-quarter ownership of Medline (MDLN) shares owned by Siren from 13F filings

Historical chart of Siren investment in Medline

Tip: Access up to 7 years of quarterly data

All positions including Medline held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medline by Siren

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 75k 42.00

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Olema Pharmaceuticals (OLMA)
Disc Medicine (IRON)
Structure Therapeutics Sponsored Ads (GPCR)
Tango Therapeutics (TNGX)
Arcus Biosciences Incorporated (RCUS)
Stoke Therapeutics (STOK)
Crinetics Pharmaceuticals In (CRNX)

View all positions for Siren

Top funds holding Medline

Carlyle
H&F Corporate Investors X
Vanguard Group
Capital Research Global Investors
BlackRock
Baillie Gifford & Co
Massachusetts Financial Services
WCM Investment Management
T. Rowe Price Investment Management
Viking Global Investors
Durable Capital Partners
Norges Bank Investment Management
Artisan Partners Limited Partnership
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capital World Investors

View all funds holding Medline